CTSS and lung adenocarcinoma: This study proposes that SHP2 may dampen lung adenocarcinoma progression by inhibiting the STAT3/STAT6 pathway in TAMs, consequently reducing M2 polarization and the secretion of factors like cathepsin, which in turn, could limit the growth and spread of lung adenocarcinoma cells.